Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






World News Story 3rd Fda Panelist Resigns Over Approval Of Alzheimer S Drug

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, World News Story 3rd Fda Panelist Resigns Over Approval Of Alzheimer S Drug is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


World News Story 3rd Fda Panelist Resigns Over Approval Of Alzheimer S Drug | RobinsPost News & Noticias

FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’


WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according ... Read More

US FDA's drug division chief resigns amid ethics concerns and lawsuit


(Reuters) -The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a ... Read More

FDA Names Pazdur Top Drug Regulator After Tidmarsh Resigns


The US Food and Drug Administration has named Richard Pazdur as its lead drug regulator, turning to a longtime official to stabilize the agency after a period of turmoil. Read More

FDA's top drug regulator resigns after federal officials probe 'serious concerns'


The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct WASHINGTON -- The head of the Food and Drug Administration’s drug center ... Read More

FDA's top drug regulator resigns after federal officials probe 'serious concerns'


WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus